Allurion Technologies, Inc. (ALUR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.041x

Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) has a cash flow conversion efficiency ratio of 0.041x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.22 Million) by net assets ($-77.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Allurion Technologies, Inc. (ALUR) market capitalisation for the company's overall valuation and market capitalisation.

Allurion Technologies, Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Allurion Technologies, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Allurion Technologies, Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Allurion Technologies, Inc. ranked by their cash flow conversion efficiency. Explore Allurion Technologies, Inc. cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
CREATIVEF. G.S.A-K ZY-23
F:19F
0.032x
Total Helium Ltd
V:TOH
0.006x
3 E Network Technology Group Ltd Class A Ordinary Shares
NASDAQ:MASK
-0.058x
River and Mercantile UK Micro Cap Investment Company Ltd
LSE:RMMC
-0.007x
General Shopping e Outlets do Brasil S.A.
SA:GSHP3
-0.028x
Edri-El
TA:EDRL
0.013x
Gentlemens Equity S.A.
PA:MLGEQ
N/A
Record PLC
LSE:REC
0.213x

Annual Cash Flow Conversion Efficiency for Allurion Technologies, Inc. (2020–2025)

The table below shows the annual cash flow conversion efficiency of Allurion Technologies, Inc. from 2020 to 2025. View today's stock price for Allurion Technologies, Inc. for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $-77.19 Million $-28.95 Million 0.375x -30.87%
2024-12-31 $-77.98 Million $-42.30 Million 0.542x -40.24%
2023-12-31 $-70.49 Million $-63.98 Million 0.908x -37.57%
2022-12-31 $-32.31 Million $-46.98 Million 1.454x +247.87%
2021-12-31 $-34.28 Million $-14.33 Million 0.418x +23780.36%
2020-12-31 $19.83K $-35.00 -0.002x --

About Allurion Technologies, Inc.

NYSE:ALUR USA Medical Devices
Market Cap
$1.02 Million
Market Cap Rank
#30677 Global
#6233 in USA
Share Price
$1.02
Change (1 day)
-2.86%
52-Week Range
$0.26 - $7.48
All Time High
$10.69
About

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring to… Read more